AI in Pharma: The End of Slow, Manual Batch Record Review?

Here’s a number worth sitting with: some pharma quality teams still spend two to three days reviewing a single batch record. Not because anything went wrong during manufacturing, but because someone has to manually check every signature, timestamp, and reading across hundreds of pages before that batch can ship.

That delay adds up fast. Multiply it across every batch a plant produces in a month, and Batch Record Review quietly becomes one of the biggest bottlenecks in the whole operation, even though the actual manufacturing might only take a fraction of that time.

The first attempt to address this was OCR, and it was somewhat successful. It creates searchable text from a scanned page. But batch records are messy in ways OCR was never built to handle. A handwritten correction. An initial that doesn’t quite match the reference. A table layout that shifts depending on who filled it out. OCR reads the shapes on the page. It does not know if the information on the page is accurate.

AI-driven document intelligence precisely bridges that gap. It is trained on the appearance of a conforming batch record, thus it does more than just extract text. Missing signature? Flagged. Reading outside spec? Flagged. Entry that doesn’t match the master batch record? Flagged automatically, before a human ever has to hunt for it. Reviewers go from reading every page to reviewing a short list of exceptions.

The payoff isn’t just speed, though that’s the obvious win. It’s also fewer errors slipping through late in a long review, and stronger audit readiness since these systems typically log every decision automatically, which matters a lot when 21 CFR Part 11 comes up during an inspection.

None of this replaces OCR entirely. It’s still the layer that gets a physical page into digital form. AI is what makes that digital form actually useful to a reviewer instead of just another wall of text to sort through.